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Background: Most evidence on chronic diseases has been collected for single diseases whereas in reality, patients
often suffer from more than one condition. There is a growing need for evidence-based answers to multimorbidity,
especially in primary care settings where family doctors (FD’s) provide comprehensive care for a high variety of
chronic conditions. This study aimed to define which disease and problem combinations would be most relevant
and useful for the development of guidelines to manage multimorbidity in primary care.
Methods: A practice-based cross sectional analysis of clinicians’ chart reviews in 543 patients aged over 65 registered
within two family practices in Ghent, Belgium. Main outcome measures were prevalence of disease and problem
combinations and association strengths.
Results: The prevalence of multimorbidity (Cumulative Illness Rating Scale >1) in the study sample is 82.6%. The most
prevalent combination is hypertension-osteoarthritis (132/543). Moderate to strong associations (Yules Q > 0.50) are
reported for 14 combinations but the corresponding prevalences are mostly below 5%. More than half of these
associations show a contribution of a psychiatric problem or a social problem.
Conclusions: This study confirms the high prevalence of multimorbidity in patients aged over 65 in primary care.
Hypertension-osteoarthritis is defined as a frequent combination however 94% of these patients have more than
two disorders. The low prevalence of specific combinations, the high prevalence of psychiatric and social problems and
the general complexity of multimorbidity will hamper the usefulness of randomized trials or guidelines at practice level.
There is a need to explore new paradigms for addressing multimorbidity.Background
Multimorbidity is clearly on the rise [1,2] and a chal-
lenge for clinical practice [3,4]. In family practice,
patients with multimorbidity are the rule rather than
the exception [5]. Yet, most available evidence to treat
chronic diseases has been collected in single disease
trials, often excluding patients with comorbid diseases.
Clinicians feel a growing need for evidence that can be
applied to patients with multiple diseases [6,7]. A pos-
sible solution to tackle this evidence gap may be to look
for specific disease combinations with a high prevalence* Correspondence: Pauline.boeckxstaens@ugent.be
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article, unless otherwise stated.and to engage in the development of randomized clinical
trials or guidelines on patients with these combinations
of diseases [8,9]. Few studies have focused on how
diseases co-occur. Mostof these studies assess comor-
bidity instead of multimorbidity. Comorbidity implies an
index disease (e.g. Chronic Obstructive Pulmonary Dis-
ease (COPD) and comorbidity) whereas multimorbidity
is defined as any co-occurrence of medical conditions
within a person. From the perspective of primary health
care multimorbidity is more relevant because general
practitioners deal with the broad spectrum of the mor-
bidity of the patient without prioritizing specific disease
categories. In order to fill the evidence-gap for multi-
morbidity we need to focus on those problems that
influence clinical management at the patient level [3,4].
However, most studies use large databases fromentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 Prevalence of the 23 problems selected for
further analysis of combinations
Problem Prevalence% n
Hypertension 48,4% 263
Osteoarthritis 47,3% 257
EENT (eye, ear, nose, throat) system 28.5% 155
Psychiatric system 20.6% 112
Neurological system 19.8% 108
Upper gastrointestinal system 14.5% 79
COPD (Chronic Obstructive Pulmonary Disease) 14,2% 77
Diabetes 14,2% 77
Ischemic heart disease 14,2% 77
Lipid disorder 14,0% 76
Social problem 14.0% 76
Cardiac rhythm disorder 13,3% 72
Overweight 12% 65
Heart failure 11% 60
Renal system 9.3% 52
Nicotine abuse 9,4% 51
Lower gastrointestinal system 8.3% 45
Depression 7,7% 42
TIA (transient ischemic attack)/CVA
(cerebrovascular accident)
7,2% 39
Cancer 7,2% 39
Osteoporosis 6,8% 37
Hepatic system 3.5% 19
Alcohol abuse 2,9% 16
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codes out of medical records or insurance claims. Datasets
based on automatized extraction of disease codes do not
necessarily identify the problems that are relevant at the
point of care [3]. They might also lead to over- or under-
estimation of diseases. For example, a disease code on low
back pain might relate to a patient that only consulted for
advice but the same disease code could also relate to a
patient with severe impairment, decreased quality of life
or intensive need for physiotherapy. This study aims to
identify the problems that influence clinical management
at the patient level in primary care in order to identify
combinations of problems that could be a relevant focus
for trials or guidelines for patients with multimorbidity.
Methods
Subjects
We conducted a practice-based cross sectional analysis
of the patient records of all patients aged 65 or older
who were registered in two community health centers
(CHC) in Ghent, Belgium. CHC’s provide interdisciplin-
ary comprehensive primary health care using a capita-
tion payment system accessible for all people residing in
the area covered by the CHC. The choice for CHC’s was
based on the fact that the capitation based system
enhances continuity of care and consequently leads to
more complete information in patients’ medical records.
The CHCs with the largest patient lists were chosen for
inclusion of patients.
Chart review
Medical records in the participating practices are based
on the problem-oriented medical record model as pro-
posed by Weed (1968) [10] in which the patient's
history, physical findings, laboratory results, etc. are
organized around patient’s problems. These medical
records include a list of all the problems of the patient
including both clearly established diagnoses (such as
diabetes II or COPD) and other problems relevant for
patient management in primary care (such as “symptom
diagnoses”, social problems,…). The underlying classi-
fication used in these records is the International
Classification of Primary Care (ICPC) [11] For each
problem presented by the patient, information is regis-
tered in the SOAP-format (subjective (S), objective (O)
assessment (A) diagnostic and treatment plans (P). Three
family doctors (PB, GG and SG), who were part of the
medical staff of the participating practices, performed a
detailed clinical review of each electronic patient record
(EPR) and its additional paper file. They assessed whether
or not a problem was of influence on the management for
that patient. For each patient this resulted in a list of all
problems with clinically relevant impact, including social
problems and relevant medical history. To provide anestimation of the prevalence of multimorbidity in the
study sample all patients were allocated a Cumulative
Illness Rating Scale (CIRS) score based on the scoring
guidelines published by Hudon [12-14]. To harmonize
the clinical assessment, data extraction and allocation of
the multimorbidity scores, 30 patient records were inde-
pendently reviewed by the three family doctors who
performed the assessment and results were compared
and discussed in a meeting to attune the assessment ap-
proach. Every patient’s problem list was anonymized and
transferred into a separate database for analysis. In order
to find a reasonable way for including all relevant but
often low prevalent problems into a sensible analysis of
combinations a process of summarization was performed
in which the research team constructed a list of 23 prob-
lems (Table 1). In this list different levels of detail were
used: some disorders like COPD, diabetes and depression
were analyzed at disease level, disorders like osteo-
arthritis and cardiac rhythm disorders were considered as
“diagnostic group” and other disorders were summarized
at the level of a body system (eg the EENT (Eye Ear Nose
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they are not considered in the CIRS social problems were
also included because of their possible relevance to the
patients’ clinical management at the point of care.
Analysis of combinations
To reveal the combinations which occur most fre-
quently, prevalences were calculated for all possible
combinations of these 23 problems. Next to the preva-
lence, Yules Q was used to measure the strength of the
association for each possible combination. Yule’s Q is a
symmetric measure taking on values between −1 and +1.
One implies perfect negative or positive association,
0 (zero) no association. Yules Q measures > 0,70 rep-
resent strong associations and Yules Q measures < 0,70
and > 0,50 represent moderate associations [15]. A per-
centile bootstrap [12] procedure with 1000 data sets was
used to estimate the 95% confidence interval for the
Yules Q coefficients. All analyses were supported by SPSS
version 19.0.
Ethical approval
Ethical approval was provided by the Ethics Committee
of Ghent University Hospital. The Belgian registration
number of the approval for the data collection per-
formed by GG and PB is B67020108605 and for the data
collection of SG is B67020108596.
Results
Study population
On 1st of October 2009, the practices under study listed
543 patients aged 65 or older. The mean age of patients
in the study sample is 73 years (range 65–97), 47,3% of
patients are male and 4,4% have no chronic disease
(CIRS =0). The prevalence of multimorbidity (CIRS > 1)
is 82.6% and 64.2% of the patients included have a CIRS
score >2 (Figure 1). The most frequently affected CIRS
domains are the endocrine (47,4%) and the musculoskeletalFigure 1 Prevalence of multimorbidity according to the CIRS.system (47%) followed by the cardiac system (30,4%). The
most frequent disorders are hypertension (48,4%), osteo-
arthritis (48,4%), COPD (14,2%), ischemic heart disease
(14,2%) and diabetes (14,2%). Table 1 reports the preva-
lence for the 23 problems which were used for further
analysis of combinations.
Combinations with a prevalence >5%
Table 2 shows all 39 problem pairs which occur fre-
quently (prevalence > 5%). The most prevalent combi-
nation is hypertension-osteoarthritis (n = 132 Yules Q
0.11 CI : −0.06-0.28). More than 2 out of 3 of these com-
binations include hypertension or osteoarthritis and only
4 of these combinations are moderately or strongly asso-
ciated (Yules Q > 0.50) : hypertension-renal system
(Yules Q 0,52), osteoarthritis –lower gastro-intestinal
system (Yules Q 0,54), psychiatric system – social problem
(Yules Q 0,66) and diabetes –overweight (Yules Q 0,74).
Combinations with a strong or moderate association
Table 3 shows all 14 combinations with a strong or mod-
erate association (Yules Q > 50). Diabetes-overweight
(Yules Q : 0,74; CI : 0,57-0,84; n = 28) and nicotine
abuse-alcohol abuse (Yules Q : 0,73; CI : 0,48-0,98; n = 6)
emerged as the most strongly associated combinations
(Yules Q >0,7). Social problems, psychiatric issues and
locomotor problems (osteoarthritis and osteoporosis) are
well represented within the list of combinations with a
moderate association (Yules’ Q 0,5-0,7). Most of these
associations (9/14) have prevalences below 5%.
Discussion
This study aimed to include those disorders that influ-
ence the clinical management of patients and used clin-
ician chart review to do so. By means of a practice-based
analysis of individual patient records it was able to assess
which combinations would be most relevant for the
development of guidelines useful at practice level in
primary care. Hypertension-osteoarthritis was identified
as a most prevalent combination of diseases (24,3% of
the study sample) but the association was not significant.
The significant associations described in Table 3 gene-
rally show very low prevalence. In general this study
indicates that the usefulness of RCT’s on disease combi-
nations will be hampered by low prevalence at practice
level, low association strengths and the fact that many
patients present with more than 2 problems (64.2% of
the study sample has a CIRS score > 2).
The combination hypertension-osteoarthritis has been
described previously as the most prevalent combination
in older persons [14]. Building evidence to manage pa-
tients with this combination could be useful because
non-steroidal-anti-inflammatory-drugs (NSAIDs) might
interfere with blood pressure control and keeping up
Table 2 Combinations with a prevalence over 5%
Problem combination Prevalence% n Yules Q (CI)
Hypertension - Osteoarthritis 24.3% 132 0.11 (−0.06-0.28)
Hypertension -EENT 17.0% 92 0.30 (0.12-0.46)
Hypertension - Psychiatric system 11.0% 60 0.13 (−0.08-0.32)
Hypertension - Neurological system 10.1% 55 0.06 (−0.15-0.27)
Hypertension – Diabetes 8.8% 48 0.32 (0.07-0.55)
Hypertension - Lipid disorder 8.7% 46 0.28 (0.04-0.49)
Hypertension - Upper gastrointestinal
system
8.5% 46 0.28 (0.04-0.47)
Hypertension - COPD 7.9% 43 0.17 (−0.07-0.40)
Hypertension - Overweight 7.9% 43 0.39 (0.13-0.61)
Hypertension - Heart failure 7.7% 42 0.47 (0.21-0.67)
Hypertension – Social problem 7.7% 42 0.16 (−0.10-0.38)
Hypertension - Rhythm disorder 7.4% 40 0.16 (−0.10-0.40)
Hypertension - Renal system 7.0% 38 0.52 (0.26-0.74)
Hypertension - Ischemic Heart Disease 6.6% 36 −0.04 (−0.29-0.18)
Osteoarthritis - EENT system 15.8% 86 0.22 (0.04-0.40)
Osteoarthritis - Psychiatric system 12.1% 66 0.29 (0.08-0.48)
Osteoarthritis - Neurological system 10.3% 56 0.11 (− 0.10-0.32)
Osteoarthritis - Upper gastrointestinal
system
9.2% 50 0.36 (0.15-0.57)
Osteoarthritis – Social problem 8.5% 46 0.30 (0.07-0.51)
Osteoarthritis - Lipid disorder 7.5% 41 0.15 (−0.08-0.37)
Osteoarthritis - Rhythm disorder 7.5% 41 0.22 (−0.03-0.46)
Osteoarthritis - overweight 7.4% 40 0.32 (0.07-0.55)
Osteoarthritis - ischemic heart disease 7.0% 38 0.05 (−0.21-0.29)
Osteoarthritis – COPD 6.4% 35 −0.04 (−0.26-0.19)
Osteoarthritis – diabetes 6.3% 34 −0.07 (−0.32-0.14)
Osteoarthritis - Lower gastrointestinal
system
6.1% 33 0.54 (0.27-0.75)
Osteoarthritis - Heart failure 5.2% 28 −0.01 (−0.29-0.25)
Osteoarthritis - Depression 5.2% 28 0.41 (0.11-0.67)
EENT system - Neurological system 9.2% 50 0.46 (0.27-0.61)
EENT system - Psychiatric system 6.6% 36 0.11 (−0.15-0.33)
EENT – Social problem 5.7% 31 0.31 (0.07-0.52)
EENT system - Upper gastrointestinal
system
5.5% 30 0.25 (−0.01-0.47)
EENT system - Rhythm disorder 5.3% 29 0.31 (0.05-0.53)
EENT system – COPD 5.1% 28 0.21 (−0.06-0.43)
Psychiatric system – Social problem 6.8% 37 0.66 (0.49-0.80)
Psychiatric system - Neurological
system
5.7% 31 0.27 (0.03-0.47)
Psychiatric system - Upper
gastrointestinal system
5.1% 28 0.43 (0.17-0.62)
Cataract- Hypertension 5.7% 31 0.35 (0.07-0.61)
Diabetes - Overweight 5.2% 28 0.74 (0.57-0.84)
CI = Confidence Interval. n = proportion and number of patients with
this combination.
Table 3 Moderate (Yules Q 0.50-0.70) and strong
associations (Yules Q > 0.7)*
Problem combination Yules Q (CI) Prevalence% n
Diabetes –overweight 0.74 (0.57-0.84) 5.1% 28
Nicotine abuse – alcohol abuse 0.73 (0.48-0.98) 1.1% 6
Social problem – psychiatric
system
0,66 (0.49-0. 80) 6.8% 37
Heart failure – renal system 0.60 (0.30-0.78) 2.8% 15
Depression – osteoporosis 0.59 (0.14-0.79) 1.5% 8
Social problem – osteoporosis 0.58 (0.25-0.77) 2.4% 13
Depression – upper
gastrointestinal system
0.58 (0.28-0.76) 2.8% 15
COPD – nicotine abuse 0.56 (0.27-0.74) 3.1% 17
Osteoarthritis – lower
gastrointestinal system
0.54 (0.29-0.74) 6.1% 33
Osteoarthritis – osteoporosis 0.53 (0.24-0.80) 5.0% 27
Social problem – depression 0.52 (0.27-0.74) 2.6% 14
Hypertension – renal system 0.52 (0.26-0.74) 7.0% 38
Osteoporosis – Upper
gastrointestinal system
0.52 (0.12-0.73) 2.2% 12
Cancer – social problem 0.50 (0.14-0.71) 2.2% 12
*only significant results (p < 0,05 are reported).
Boeckxstaens et al. BMC Family Practice 2014, 15:159 Page 4 of 6
http://www.biomedcentral.com/1471-2296/15/159an active life style can be difficult when suffering
from osteoarthritis. Most other combinations with a
considerable prevalence (which we have set at >5%)
often include diagnostic groups (e.g. rhythm disorders)
or body systems (e.g. neurological system) to which
guidelines are not directly applicable. The combina-
tions hypertension-diabetes, hypertension-lipid disorder,
hypertension-overweight, hypertension-ischemic heart dis-
ease, hypertension-heart failure and diabetes-overweight
are quite well covered within disease-specific guidelines
because these combinations concern well established co-
morbid conditions based on causal associations [16,17].
Many of the other combinations include osteoarthritis.
Despite the existence of osteoarthritis guidelines [18], a
standardized approach of the disorder is hampered due
to the differing localization and the varying impact of
the disorder on functional limitations and quality of life.
Other combinations with considerable prevalence include
mental health problems and social problems which is not
only related to the high prevalence of both problems in
this sample (psychiatric disorders (20,6%) and social
problems (14,0%)) because remarkably, these prob-
lems are also highly represented in the associations with
a moderate to strong correlation (Table 3). The import-
ance of psychiatric comorbidity has been described previ-
ously [19] but to our knowledge there were no studies
including social problems. From the perspective of clin-
ical care psychosocial problems are very relevant as they
can hamper compliance to disease specific guidelines for
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providers. Qualitative inquiries in family doctors have
also described them to be the main challenges within the
management of multimorbidity [7].
Multimorbidity is not limited to a specific set of
chronic conditions
Our study confirms the low prevalence of specific
combinations described in earlier studies and high-
lights the heterogeneity of multimorbidity described in
other populations [19-22]. The study of Van Oostrom
et al. [19] selected 9 chronic diseases for analysis of
disease pairs with 29 other disease codes. Only one
combination (depression-anxiety) was found to have a
prevalence over 5% and 70% of patients had a comor-
bid disease which was not included within the nine
most common chronic conditions. Despite the fact
that Van Oostrom et al. included a younger population
(patients aged over 55) and provided a less compre-
hensive assessment of multimorbidity, their main results
are in line with our findings showing a wide variety in
multimorbidity which is not limited to a specific list of
chronic conditions.
Tailored instead of standardized care
Our results have also clearly indicated that the useful-
ness of guidelines on disease combinations will not
only be hampered by the low prevalence of the com-
binations, but even more by the fact that 94% of the
patients with hypertension and osteoarthritis had add-
itional problems and 64.2% of the patients in this
sample had a CIRS > 2. Van den Bussche et al. [21]
have described that 64% of patients with three or more
diseases (out of a list of 64) were defined with a triade
within the six most prevalent conditions (hypertension,
lipid disorder, diabetes, low back pain, osteoarthritis,
ischemic heart disease). They suggested that an ad-
justment and alignment of clinical guidelines for these
six conditions would constitute a big step towards an
adaptation of guidelines for multimorbid patients. How-
ever, these six problems include conditions which
might have a very differing impact at patient level (for
example low back pain and osteoarthritis) which may
hamper the use of standardized guidelines. Moreover,
our study has indicated a considerable prevalence of
mental health problems and social problems which
will also be less easily included in standardized guide-
lines and programs because they often require tailored
and individualized instead of programmed and stan-
dardized care.
Strengths and limitations
The main strength of this study is that the morbidity
estimates are derived from chart review rather thanautomated diagnostic codes [22]. This enabled a com-
prehensive assessment of multimorbidity including
merely problems that were significant for the clinical
management of the patient and enabling the inclusion of
all problems whereas most studies are obliged to a pre-
selection of chronic diseases [21-23]. This practice-based
individualized assessment by family doctors provides a
comprehensive insight in the day to day presentation of
multimorbidity in primary care. The individualized as-
sessment by clinicians may hamper validity of data but
first, chart review within primary care has been validated
for the assessment of multimorbidity [24] and second,
the assessment approach has been harmonized. The re-
sults of this study require cautious interpretation mostly
because prevalence figures on multimorbidity are highly
determined by study design and datasources [20,21].
Fortin et al. have indicated that prevalence estimates
are higher in the primary care setting than in the gen-
eral population [21,22]. Moreover, because we were
able to include every condition instead of a limited list
higher prevalence figures are to be expected [21]. Be-
cause the aim of this specific study included an assess-
ment of multimorbidity the way it presents to family
doctors we believe our results indicate that the useful-
ness of guidelines on guidelines for disease combina-
tions will be hampered at the level of clinical practice.
A main disadvantage of our method is that detailed
clinical review is not feasible for larger samples. The
analysis of only 543 patients in two family practices
in Belgium should be considered a limitation as is
the fact that we only assessed combinations whereas
many patients have more than two problems. The
generalizability of our results may also be hampered
due to the particularly deprived population within the
CHC’s and the inclusion of older patients. However, the
high morbidity load and complexity of this population
should have been suitable to retrieve the combinations
which in the end are relevant at practice level in primary
care.
Conclusion
Our results show that patients with multimorbidity often
have complex and unique combinations of problems.
Low prevalence of disease combinations at practice level
and the fact that many patients have more than two
problems which influence clinical management make it
unlikely that performing trials or developing guidelines
for people with specific combinations will ever be useful
at the level of clinical practice. The need for an individ-
ual approach is further emphasized by the high preva-
lence of social and psychiatric problems. We need to
explore new generic ways and paradigms to approach
patients with multimorbidity which allow to tailor care
to each individual patient [19].
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